Nakamura, K.; Yoshikawa, N.; Mizuno, Y.; Ito, M.; Tanaka, H.; Mizuno, M.; Toyokuni, S.; Hori, M.; Kikkawa, F.; Kajiyama, H.
Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy. Cancers 2021, 13, 1141.
https://doi.org/10.3390/cancers13051141
AMA Style
Nakamura K, Yoshikawa N, Mizuno Y, Ito M, Tanaka H, Mizuno M, Toyokuni S, Hori M, Kikkawa F, Kajiyama H.
Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy. Cancers. 2021; 13(5):1141.
https://doi.org/10.3390/cancers13051141
Chicago/Turabian Style
Nakamura, Kae, Nobuhisa Yoshikawa, Yuko Mizuno, Miwa Ito, Hiromasa Tanaka, Masaaki Mizuno, Shinya Toyokuni, Masaru Hori, Fumitaka Kikkawa, and Hiroaki Kajiyama.
2021. "Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy" Cancers 13, no. 5: 1141.
https://doi.org/10.3390/cancers13051141
APA Style
Nakamura, K., Yoshikawa, N., Mizuno, Y., Ito, M., Tanaka, H., Mizuno, M., Toyokuni, S., Hori, M., Kikkawa, F., & Kajiyama, H.
(2021). Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy. Cancers, 13(5), 1141.
https://doi.org/10.3390/cancers13051141